|
Market Closed -
Oslo Bors
18:45:00 13/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 227.00 NOK | -0.44% |
|
-0.44% | -12.36% |
| 06-10 | Odin Small Cap gains 4.90 percent in May - slightly trims Mycronic position | FW |
| 05-12 | Danske Bank raises Medistim price target to NOK 320 (310), reiterates Buy - BN | FW |
Company Valuation: Medistim ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,693 | 4,216 | 3,912 | 2,738 | 4,735 | 4,152 | - | - |
| Change | - | -37.01% | -7.22% | -30.01% | 72.95% | -12.31% | - | - |
| Enterprise Value (EV) 1 | 6,581 | 4,216 | 3,866 | 2,584 | 4,561 | 4,014 | 4,000 | 3,977 |
| Change | - | -35.93% | -8.31% | -33.16% | 76.51% | -11.98% | -0.35% | -0.59% |
| P/E | 73.8x | 37x | 37.7x | 26.4x | 29.7x | 24.8x | 23.3x | 20.7x |
| PBR | 21.9x | - | - | - | 10.1x | 8.51x | 7.63x | 6.91x |
| PEG | - | 1.5x | -4.13x | - | 0.6x | 4.41x | 3.6x | 1.7x |
| Capitalization / Revenue | 15.7x | 8.57x | 7.43x | 4.87x | 6.77x | 5.41x | 5.01x | 4.63x |
| EV / Revenue | 15.4x | 8.57x | 7.34x | 4.59x | 6.52x | 5.23x | 4.83x | 4.43x |
| EV / EBITDA | 47.1x | 25.6x | 24.9x | 16.6x | 20.6x | 16.5x | 15.2x | 13.6x |
| EV / EBIT | 56.6x | 29.8x | 29.4x | 19.7x | 23.2x | 18.4x | 17.1x | 15.1x |
| EV / FCF | 56.4x | - | 46.3x | 22.1x | 29.3x | 36.5x | 26.9x | 24x |
| FCF Yield | 1.77% | - | 2.16% | 4.52% | 3.41% | 2.74% | 3.71% | 4.17% |
| Dividend per Share 2 | 3.75 | - | 4.5 | 6 | 8 | 8.5 | 7.87 | 8.505 |
| Rate of return | 1.02% | - | 2.1% | 4.01% | 3.09% | 3.73% | 3.45% | 3.73% |
| EPS 2 | 4.98 | 6.24 | 5.67 | 5.67 | 8.71 | 9.2 | 9.795 | 11 |
| Distribution rate | 75.3% | - | 79.4% | 106% | 91.8% | 92.4% | 80.3% | 77.3% |
| Net sales 1 | 427.3 | 491.9 | 526.4 | 562.6 | 699.8 | 768 | 829 | 897 |
| EBITDA 1 | 139.7 | 164.5 | 155.1 | 155.6 | 221 | 244 | 263.5 | 292 |
| EBIT 1 | 116.3 | 141.3 | 131.4 | 131.1 | 196.2 | 218 | 234.5 | 263 |
| Net income 1 | 90.9 | 114 | 103.8 | 103.8 | 159.2 | 168 | 179.5 | 201 |
| Net Debt 1 | -112.4 | - | -46.1 | -154.2 | -174.6 | -138 | -152 | -175.5 |
| Reference price 2 | 367.50 | 231.00 | 214.00 | 149.50 | 259.00 | 228.00 | 228.00 | 228.00 |
| Nbr of stocks (in thousands) | 18,213 | 18,252 | 18,279 | 18,314 | 18,283 | 18,293 | - | - |
| Announcement Date | 25/02/22 | 01/03/23 | 29/02/24 | 28/02/25 | 27/02/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.78x | 5.25x | 16.53x | 3.73% | 440M | |
| 30.03x | 5.32x | 20.39x | 0.31% | 223B | |
| 34.49x | 6.25x | 19.81x | 0.71% | 145B | |
| 44.03x | 11.48x | 25.39x | -.--% | 142B | |
| 19.23x | 3.9x | 12.66x | -.--% | 74.52B | |
| 36.77x | 7.4x | 23.4x | -.--% | 53.63B | |
| 19.55x | 2.33x | 11.7x | 2.61% | 50.14B | |
| 28.83x | 5.75x | 19.66x | 0.69% | 41.87B | |
| 88.89x | 6.94x | 21.06x | -.--% | 40.89B | |
| 15.48x | 1.78x | 9.95x | 0.22% | 32.65B | |
| Average | 34.21x | 5.64x | 18.05x | 0.83% | 80.35B | |
| Weighted average by Cap. | 34.44x | 6.36x | 19.68x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MEDI Stock
- Valuation Medistim ASA
Select your edition
All financial news and data tailored to specific country editions
